| The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review M Tonneau, A Elkrief, D Pasquier, TP Del Socorro, M Chamaillard, ... Radiotherapy and Oncology 156, 1-9, 2021 | 55 | 2021 |
| Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges. TM Wise-Draper, H Bahig, M Tonneau, V Karivedu, B Burtness American Society of Clinical Oncology Educational book. American Society of …, 2022 | 26 | 2022 |
| Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors M Tonneau, A Nolin-Lapalme, S Kazandjian, E Auclin, J Panasci, ... Oncoimmunology 11 (1), 2096535, 2022 | 14 | 2022 |
| Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer E Auclin, J Benitez-Montanez, M Tagliamento, F Parisi, T Gorria, ... Lung Cancer 178, 116-122, 2023 | 11 | 2023 |
| Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study S Yolchuyeva, E Giacomazzi, M Tonneau, F Lamaze, M Orain, ... Scientific Reports 13 (1), 11065, 2023 | 6 | 2023 |
| Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial … H Bahig, M Tonneau, N Blais, P Wong, E Filion, MP Campeau, T Vu, ... Clinical and Translational Radiation Oncology 33, 115-119, 2022 | 6 | 2022 |
| Stereotactic body radiotherapy for intramedullary metastases: a retrospective series at the Oscar Lambret center and a systematic review M Tonneau, R Mouttet-Audouard, F Le Tinier, X Mirabel, D Pasquier BMC cancer 21, 1-10, 2021 | 5 | 2021 |
| A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy M Tonneau, C Richard, B Routy, MP Campeau, T Vu, E Filion, D Roberge, ... Radiotherapy and Oncology 185, 109697, 2023 | 4 | 2023 |
| A radiomics-clinical model predicts overall survival of non-small cell lung cancer patients treated with immunotherapy: a multicenter study S Yolchuyeva, E Giacomazzi, M Tonneau, L Ebrahimpour, FC Lamaze, ... Cancers 15 (15), 3829, 2023 | 4 | 2023 |
| Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors’ response in non-small cell lung cancer: a multicenter cohort study M Tonneau, K Phan, VSK Manem, C Low-Kam, F Dutil, S Kazandjian, ... Frontiers in Oncology 13, 1196414, 2023 | 4 | 2023 |
| OA07. 06 Second line treatment outcomes after progression on immunotherapy plus chemotherapy (IO-CT) in advanced non-small cell lung cancer (aNSCLC) E Auclin, J Benitez-Montanez, T Gorria, R Garcia-Campelo, N Dempsey, ... Journal of Thoracic Oncology 17 (9), S22, 2022 | 4 | 2022 |
| The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy F Proulx-Rocray, B Routy, R Nassabein, W Belkaid, D Tran-Thanh, J Malo, ... Cancer Treatment and Research Communications 37, 100767, 2023 | 3 | 2023 |
| Radiothérapie stéréotaxique dans le cancer du pancréas localement avancé: Revue de la littérature M Tonneau, T Lacornerie, X Mirabel, D Pasquier Cancer/Radiothérapie 25 (3), 283-295, 2021 | 3 | 2021 |
| Stereotactic body radiotherapy for locally advanced pancreatic cancer: A systemic review M Tonneau, T Lacornerie, X Mirabel, D Pasquier Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie …, 2021 | 3 | 2021 |
| Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma C Hes, A Desilets, M Tonneau, O El Ouarzadi, MDF Sousa, H Bahig, ... Oral Oncology 148, 106623, 2024 | 2 | 2024 |
| Role of the gut microbiota in the development of immune-mediated diarrhea and colitis induced by immune checkpoint inhibitors K Diop, B Myriam, W Belkaid, A Nolin-Lapalme, J Malo, M Tonneau, ... Cancer Research 82 (12_Supplement), 3524-3524, 2022 | 2 | 2022 |
| Association between immune-related adverse events and microbiome composition in patients with advanced non–small cell lung cancer treated with immunotherapy. M Tonneau, C Richard, A Nolin-Lapalme, E Auclin, M Benlaifaoui, ... Journal of Clinical Oncology 40 (16_suppl), 9036-9036, 2022 | 2 | 2022 |
| Radiotherapy for patients with early-stage glottic squamous cell carcinoma of the larynx: Interest of hypofractionation? M Tonneau, R Matta, S Lals, X Mirabel, F Crop, T Lacornerie, D Pasquier, ... Cancer Radiotherapie: Journal de la Societe francaise de radiotherapie …, 2021 | 2 | 2021 |
| CXCL13 positive cells localization predict response to anti-PD-1/PD-L1 in pulmonary non-small cell carcinoma F Vahidian, FC Lamaze, C Bouffard, F Coulombe, A Gagné, F Blais, ... Cancers 16 (4), 708, 2024 | 1 | 2024 |
| The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study AK Dia, L Ebrahimpour, S Yolchuyeva, M Tonneau, FC Lamaze, M Orain, ... Cancers 16 (2), 348, 2024 | 1 | 2024 |
